logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

DALIPAL Holdings (01921) will resume trading on January 13th.

date
08:47 13/01/2026
avatar
GMT Eight
Dali Purse (01921) issued an announcement that the company's shares will resume trading on January 13, 2026 at 9:00 am.
DALIPAL HLDG (01921) announced that the company's shares will resume trading on January 13, 2026 at 9:00 AM.
Related Articles
China Stock
Guotai Haitong: Short-term beer industry prosperity under pressure, suggesting increased holdings in strong regional wine companies and industry leaders.
HK Stock Market Move | BOAN BIOTECH (06955) rose more than 6% and the Disifinib injection was approved to be listed in Bolivia. Plans to submit application for market approval in multiple countries.
HK Stock Market Move | Henlius (02696) rises by over 8%, broad-spectrum anti-tumor PD-L1 ADC HLX43 Phase II data for esophageal squamous cell carcinoma released for the first time
Guotai Haitong: Short-term beer industry prosperity under pressure, suggesting increased holdings in strong regional wine companies and industry leaders.
China Stock
HK Stock Market Move | BOAN BIOTECH (06955) rose more than 6% and the Disifinib injection was approved to be listed in Bolivia. Plans to submit application for market approval in multiple countries.
HK Stock Market Move | Henlius (02696) rises by over 8%, broad-spectrum anti-tumor PD-L1 ADC HLX43 Phase II data for esophageal squamous cell carcinoma released for the first time
RECOMMEND
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
icon
10/01/2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
icon
10/01/2026
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
icon
10/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.